News | February 11, 2008

FDA to Host Best Practices for Cardviovascular Devices Conference

February 12, 2008 – The FDA, National Heart Lung & Blood Institute (NHLBI) and National Science Foundation, are hosting “Workshop on Computer Methods for Cardiovascular Devices,” on March 18-19, 2008, which will address computational mechanics and computing methods as part of an industry movement to employ best practices when using cardiovascular devices.

The conference will cover topics such as cardiac mechanics; cardiac fluid dynamics; blood flow in arteries; vessel wall mechanics; growth and remodeling and thrombosis; stents ; artificial heart valves; ventricular assist devices; and cardiac rhythm management. Additionally, the conference will address regulatory perspectives for best practices and tools needed to improve CV device modeling.

Registration is being managed by B L Seamon Corp. You may register online, or by calling B L Seamon. Onsite registration will not be available.

For more information: www.blsmeetings.net/H1369 or www.biomedical-market-news.com or www.fda.hhs.gov

Related Content

FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
Onyx DES 2.0 mm stent meets primary endpoints in small vessels
News | June 12, 2017
June 12, 2017 – The Medtronic Resolute Onyx Drug-Eluting Stent (DES) met its primary endpoint of target lesion failur
First Pennsylvania Patient Treated in LEADERS FREE II Trial of BioFreedom Drug-Coated Stent
News | Stents Drug Eluting| May 12, 2017
PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania in a trial assessing the safety and...
Resolute Onyx DES, drug eluting stent, medtronic, gains FDA approval
Technology | Stents Drug Eluting| May 01, 2017
May 1, 2017 — The U.S.
Sponsored Content | Videos | Stents Drug Eluting| May 01, 2017
This video, provided by Medtronic, demonstrates the Resolute Onyx coronary stent.
Tryton Medical, Side Branch Stent, first U.S. commercial case, New York-Presbyterian Hospital, Columbia University Medical Center
News | Stents Bifurcation| March 31, 2017
Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side Branch Stent was...
Sponsored Content | Videos | Stents Bioresorbable| March 30, 2017
Stephen Ellis, M.D., professor of medicine and director of interventional cardiology at Cleveland Clinic, discusses t
Gore Tigris Vascular Stent, Health Canada approval, PAD, peripheral artery disease
News | Stents Peripheral| March 16, 2017
W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris Vascular Stent, a...
Sponsored Content | Videos | Stents Bifurcation| March 06, 2017
This video, provided by Tryton, demonstrates the implantation of the Tryton Side Branch Stent.
Overlay Init